Skip to content

Running Title: PPAR-γ, RXR-α, and VDR Expressions in Periodontitis

PPAR-γ, RXR-α, and VDR Expressions in Periodontitis Patients With Different Stage and Grade Involvement

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04018144
Enrollment
45
Registered
2019-07-12
Start date
2019-08-01
Completion date
2020-03-01
Last updated
2019-07-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Periodontitis

Keywords

Periodontitis, PPAR-γ, RXR-α, VDR

Brief summary

Objective: The present study aimed to determine the expressions of nuclear receptors PPAR (Peroxisome proliferative activator receptor)-γ, RXR (Retinoid X receptor)-α, and vitamin D receptor (VDR) in healthy volunteers and periodontitis patients with different grade involvement. Methods: Group-1; healthy individuals, Group-2; periodontitis patients-stage 3 grade B, (H-GradeB), Group-3; periodontitis patients-stage 3 grade C, (D-GradeC). Clinical parameters as plaque index (PI), gingival index (GI) and clinical attachment levels (CAL) were measured. Fibroblast and inflammatory cells, PPAR-γ, RXR-α, and VDR levels were determined in histological slides.

Interventions

DIAGNOSTIC_TESTGingiva Biopsy Sampling

Gingival samples of healthy individuals were collected by gingivectomy or crown lengthening procedure in the routine treatment protocol or before orthodontically indicated tooth extraction. Gingival samples of periodontitis patients were obtained during the scaling and root planning procedure. Posterior maxillary teeth (#4, #5, #6, and #7) were chosen for gingival sampling.

Sponsors

Tokat Gaziosmanpasa University
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

* systemic health * no drug use * no previous periodontal treatment within six months * no tobacco use

Exclusion criteria

* pregnant or lactating women * patients used antibiotics in the last 6 months

Design outcomes

Primary

MeasureTime frameDescription
Inflammatory cell countsDuring histological tissue processingConnective tissues were evaluated, and inflammatory cell infiltration were counted in the H&E stained slides using a light microscope (Nikon Eclipse, E 600, Tokyo, Japan). For cell counting, connective tissue neighboring gingival epithelium was marked, and a cell counting frame of 10000 µm2 was marked. Inflammatory cells (neutrophil, lymphocyte, eosinophil, and macrophage cells) within the frame were counted. The measurements were performed from three different points, and the mean of these three measurements was recorded.
Fibroblasts countsDuring histological tissue processingFor cell counting, connective tissue neighboring gingival epithelium was marked, and a cell counting frame of 10000 µm2 was marked. The fibroblast counts within the frame were counted. The measurements were performed from three different points, and the mean of these three measurements was recorded.
PPAR (Peroxisome proliferative activator receptor)-γDuring histological tissue processingPPAR (Peroxisome proliferative activator receptor)-γ levels were determined via immunohistochemistry.
RXR (Retinoid X receptor)-αDuring histological tissue processingRXR (Retinoid X receptor)-α levels were determined via immunohistochemistry.
Vitamin D receptor (VDR)During histological tissue processingVitamin D receptor (VDR) levels were determined via immunohistochemistry.

Countries

Turkey (Türkiye)

Contacts

Primary ContactOzkan KARATAS
dtokaratas@hotmail.com05335141032

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026